Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Muscle related signs and symptoms NEC
ADR ID BADD_A02886
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.03      Muscle related signs and symptoms NEC
Description Not Available
MedDRA Code 10028326
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01580Nitrous oxide0.000697%
BADD_D01585Norethindrone0.001066%
BADD_D01586Norethindrone acetate--
BADD_D01587Norfloxacin--
BADD_D01588Nortriptyline--
BADD_D01590Nuvaring--
BADD_D01592Obeticholic acid--
BADD_D01595Octreotide acetate--
BADD_D01596Ofatumumab--
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine0.003473%
BADD_D01600Olanzapine pamoate--
BADD_D01602Olmesartan0.000105%
BADD_D01605Olopatadine--
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01609Omacetaxine mepesuccinate--
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01614Omeprazole0.000067%
BADD_D01615Omeprazole magnesium--
BADD_D01616Onabotulinumtoxina--
BADD_D01617Ondansetron--
BADD_D01618Ondansetron hydrochloride--
BADD_D01620Oprelvekin--
BADD_D01621Optimark--
BADD_D01622Orciprenaline--
BADD_D01623Oritavancin0.000569%
BADD_D01624Orlistat0.018097%
The 29th Page    First    Pre   29 30 31 32 33    Next   Last    Total 46 Pages
ADReCS-Target
ADR Term Drug Name Target